- Oral presentation
- Open Access
Identification of wheat proteins involved in active stage of celiac disease: are gamma gliadins the major disease-specific antigens?
© Srinivasan et al; licensee BioMed Central Ltd. 2011
- Published: 12 August 2011
- Celiac Disease
- Individual Protein
- Celiac Disease Patient
- Purification Protocol
- Elution Fraction
Celiac disease (CD) is caused by a severe immune response to wheat gliadins and glutenins. It is thought that gliadin-specific T cells mediate mucosal damage and generation of IgA/IgG class anti-gliadin antibodies, but individual protein antigens and epitopes have not been studied in detail.
To characterize wheat antigens with ability to initiate and sustain CD.
We developed a method wherein the alcohol extracted gliadins was fractionated in two steps of ion-exchange chromatography, Sulphopropyl (SP) was used for the first step and the flow through (FT) fraction obtained was further fractionated using DEAE. Each generated fraction’s reactivity to serum IgA, from clinically well defined CD (active/diet) patients and non-CD patients was analyzed. Identification of disease specific antigens in the fractions was attempted using mass spectrometry and N-terminal sequencing.
Patients with active disease showed strong IgA reactivity to proteins in all the fractions. Interestingly, we found that non-CD and CD patients under diet, exhibited background IgA reactivity which were mainly restricted to the elution fraction of SP but did not react with FT SP and FT DEAE fractions. The latter fractions hence appeared useful to identify patients with active forms of CD. Mass Spectrometry and N-terminal sequencing revealed that gamma-gliadins were enriched in FT SP and FT DEAE fractions.
We report here a purification protocol for enriching IgA-reactive antigens specifically recognised by active CD patients. This fraction containing majorly gamma-gliadins will be useful for characterizing individual proteins, involved in disease and for developing diagnostic and treatment strategies.
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.